CVM logo

CEL-SCI (CVM) Company Overview

Profile

Full Name:

CEL-SCI Corporation

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

December 8, 1983

Indexes:

Not included

Description:

CVM (CEL-SCI) is a biotechnology company focused on developing innovative therapies for cancer and infectious diseases. Their main product, Multikine, aims to enhance the immune response in cancer patients. The company is dedicated to improving treatment options and patient outcomes through advanced research and clinical trials.

Events Calendar

Earnings

Next earnings date:

Feb 14, 2025

Recent quarterly earnings:

Aug 14, 2024

Recent annual earnings:

Dec 30, 2020
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Aug 28, 1996
Splits

Next split:

N/A

Recent split:

Jun 15, 2017

Analyst ratings

Recent major analysts updates

Jul 12, 23 EF Hutton
Buy
Mar 9, 23 EF Hutton
Buy
Dec 29, 22 EF Hutton
Buy
Aug 25, 22 EF Hutton
Buy
Apr 7, 22 EF Hutton
Buy
Jan 13, 20 HC Wainwright & Co.
Buy
Jan 13, 20 H.C. Wainwright
Buy
Feb 20, 13 Taglich Brothers
Speculative Buy
Feb 13, 13 Chardan Capital
Buy
Jan 14, 13 Laidlaw & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Why Is CEL-SCI (CVM) Stock Down 23% Today?
Why Is CEL-SCI (CVM) Stock Down 23% Today?
Why Is CEL-SCI (CVM) Stock Down 23% Today?
CVM
InvestorPlaceJuly 18, 2023

CEL-SCI (NYSEMKT: CVM ) stock is dropping on Tuesday after the biotechnology company announced details of a public share offering. CEL-SCI is offering up 2.5 million shares of its common stock at a price of $2 per share.

FAQ

  • What is the ticker symbol for CEL-SCI?
  • Does CEL-SCI pay dividends?
  • What sector is CEL-SCI in?
  • What industry is CEL-SCI in?
  • What country is CEL-SCI based in?
  • When did CEL-SCI go public?
  • Is CEL-SCI in the S&P 500?
  • Is CEL-SCI in the NASDAQ 100?
  • Is CEL-SCI in the Dow Jones?
  • When was CEL-SCI's last earnings report?
  • When does CEL-SCI report earnings?
  • Should I buy CEL-SCI stock now?

What is the ticker symbol for CEL-SCI?

The ticker symbol for CEL-SCI is NYSE American:CVM

Does CEL-SCI pay dividends?

No, CEL-SCI does not pay dividends

What sector is CEL-SCI in?

CEL-SCI is in the Healthcare sector

What industry is CEL-SCI in?

CEL-SCI is in the Biotechnology industry

What country is CEL-SCI based in?

CEL-SCI is headquartered in United States

When did CEL-SCI go public?

CEL-SCI's initial public offering (IPO) was on December 8, 1983

Is CEL-SCI in the S&P 500?

No, CEL-SCI is not included in the S&P 500 index

Is CEL-SCI in the NASDAQ 100?

No, CEL-SCI is not included in the NASDAQ 100 index

Is CEL-SCI in the Dow Jones?

No, CEL-SCI is not included in the Dow Jones index

When was CEL-SCI's last earnings report?

CEL-SCI's most recent earnings report was on Aug 14, 2024

When does CEL-SCI report earnings?

The next expected earnings date for CEL-SCI is Feb 14, 2025

Should I buy CEL-SCI stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions